Understanding how a protein complex affects immune cells in cancer treatment
Regulation of Zbtb44-Eomes complex in CD8+T cells and anti-tumor immunity
This study is looking at how a specific protein complex affects immune cells that help fight tumors, with the goal of finding ways to make these cells work better in cancer treatment, which could lead to improved therapies for patients with solid tumors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11041014 on NIH RePORTER |
What this research studies
This research investigates the role of a protein complex involving Zbtb44 and Eomes in CD8+ T cells, which are crucial for fighting tumors. The study aims to uncover how this complex influences the effectiveness of these immune cells in the tumor environment, particularly when they become dysfunctional. By using advanced techniques like CRISPR-Cas9, the researchers will explore ways to enhance the anti-tumor activity of these cells, potentially leading to improved cancer therapies. Patients may benefit from insights that could lead to more effective treatments for solid tumors.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with solid tumors who may benefit from enhanced immune therapies.
Not a fit: Patients with hematological cancers or those not eligible for immune-based therapies may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for enhancing the immune response against solid tumors in cancer patients.
How similar studies have performed: Other research has shown promising results in enhancing T cell function through similar molecular targeting approaches, indicating potential for success in this area.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Poojary, Venuprasad K — Ut Southwestern Medical Center
- Study coordinator: Poojary, Venuprasad K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.